Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Cardiac Biomarkers Testing Global Market Report 2025
Request Sample Buy Now
Global Cardiac Biomarkers Testing Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Cardiac Biomarkers Testing Global Market Report 2025

By Biomarkers Type (Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP and NT-proBNP), Ischemia Modified albumin (IMA), Other Biomarkers Types), By Application (Congestive Heart Failure, Acute Coronary Syndrome, Myocardial Infarction, Atherosclerosis, Other Applications), By End-User (Hospitals, Specialty Clinics) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Cardiac Biomarkers Testing Market Overview

• Cardiac Biomarkers Testing market size has reached to $13.48 billion in 2024

• Expected to grow to $23.24 billion in 2029 at a compound annual growth rate (CAGR) of 11.7%

• Growth Driver: Rising Prevalence Of Cardiovascular Diseases Fuels Growth In The Cardiac Biomarkers Testing Market

• Market Trend: Strategic Partnerships Enhance Early Detection And Management Of Heart Conditions

• North America was the largest region in 2024.

What Is Covered Under Cardiac Biomarkers Testing Market?

Cardiac biomarkers testing refers to the tests to evaluate the quantities of cardiac biomarkers in blood. It is used to diagnose, assess, and keep track of people who may have acute coronary syndrome (ACS).

The types of biomarkers in cardiac biomarkers testing are creatine kinase (CK-MB), troponins, myoglobin, natriuretic peptides (BNP and NT-proBNP), ischemia-modified albumin (IMA) and others. Creatine kinase (CK-MB) refers to a blood test that looks for a particular enzyme. The various applications involved are congestive heart failure, acute coronary syndrome, myocardial infarction, atherosclerosis and others, with hospitals and specialty clinic end-users.

Cardiac Biomarkers Testing Global Market Report 2025 Market Size and growth rate 2025 to 2029: Graph

What Is The Cardiac Biomarkers Testing Market Size 2025 And Growth Rate?

The cardiac biomarkers testing market size has grown rapidly in recent years. It will grow from $13.48 billion in 2024 to $14.95 billion in 2025 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to increasing incidence of cardiovascular diseases, aging population, awareness and education initiatives, government initiatives and healthcare policies, increasing healthcare expenditure.

What Is The Cardiac Biomarkers Testing Market Growth Forecast?

The cardiac biomarkers testing market size is expected to see rapid growth in the next few years. It will grow to $23.24 billion in 2029 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to personalized medicine, rising global burden of cardiovascular diseases, integration of artificial intelligence (ai) in diagnostics, expansion of point-of-care testing, increasing emphasis on early disease detection. Major trends in the forecast period include technological advancements, advancements in ai-assisted diagnostics, point-of-care testing (POCT) growth, multiplexing capabilities, biomarker discovery and validation.

The forecast of 11.7% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. cardiology clinics by driving up costs of high-sensitivity cardiac troponin testing kits imported from Sweden and South Korea, exacerbating ACS diagnostic expenses and increasing cardiovascular monitoring burdens. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Cardiac Biomarkers Testing Market Segmented?

1) By Biomarkers Type: Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA), Other Biomarkers Types

2) By Application: Congestive Heart Failure, Acute Coronary Syndrome, Myocardial Infarction, Atherosclerosis, Other Applications

3) By End-User: Hospitals, Specialty Clinics

Subsegments:

1) By Creatine Kinase (CK-MB): Total CK-MB, CK-MB Mass

2) By Troponins: Cardiac Troponin I (cTnI), Cardiac Troponin T (cTnT)

3) By Myoglobin: Total Myoglobin

4) By Natriuretic Peptides: B-Type Natriuretic Peptide (BNP), N-Terminal Pro B-Type Natriuretic Peptide (NT-ProBNP)

5) By Ischemia Modified Albumin (IMA): IMA Levels

6) By Other Biomarkers Types: C-Reactive Protein (CRP), Heart-Type Fatty Acid-Binding Protein (H-FABP), Soluble ST2

What Is Driving The Cardiac Biomarkers Testing Market? Rising Prevalence Of Cardiovascular Diseases Fuels Growth In The Cardiac Biomarkers Testing Market

The increasing prevalence of cardiovascular diseases is expected to boost the growth of the cardiac biomarkers testing market going forward. Cardiovascular disease refers to a type of condition that affects the heart or blood vessels. Cardiac biomarker tests assist in determining the levels of biomarkers to immediately determine the severity of a heart attack and its magnitude. Hence, an increase in the prevalence of cardiovascular diseases will lead to an increase in the demand for cardiac biomarker testing solutions. For instance, in August 2022, according to the American College of Cardiology, a US-based professional medical organization, the expected rates of cardiovascular risk factors and disease will considerably rise in the United States by the year 2060. Therefore, an increase in the prevalence of cardiovascular diseases is driving the growth of the cardiac biomarkers testing industry.

What Is Driving The Cardiac Biomarkers Testing Market? Revolutionizing Cardiovascular Care Through The Intersection Of Cardiac Biomarkers Testing And Personalized Medicine

The growing demand for personalized medical solutions is expected to propel the growth of the cardiac biomarkers testing market going forward. Personalized medicine refers to an innovative approach to medical treatment and healthcare that tailors medical decisions, practices, interventions, and drug therapies to the individual patient. The integration of cardiac biomarkers testing into personalized medicine enhances the precision of cardiovascular care, leading to more effective prevention, early detection, and treatment strategies tailored to individual patient needs. For instance, in October 2022, according to reports published by STAT, a US-based health-oriented news company, there were more than 75,000 genetic testing products and 300 personalized medicines. Therefore, the growing demand for personalized medicine is driving the growth of the cardiac biomarkers testing industry.

Who Are The Major Players In The Global Cardiac Biomarkers Testing Market?

Major companies operating in the cardiac biomarkers testing market include Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Biomérieux SA, Becton Dickinson and Company, Randox Laboratories Ltd., Enzo Biochem Inc., Creative Diagnostics Inc., Merck Co. & KGaA, Beckman Coulter Inc., QIAGEN N.V., PerkinElmer Inc., Tosoh Corporation, Eurolyser Diagnostica GmbH, Cortez Diagnostics Inc., DIALAB GmbH, CardioGenics Holdings Inc., Lepu Medical Technology (Beijing) Co. Ltd., Biosynex SA, Charles River Laboratories, Quidel Corporation, Life Diagnostics, Trinity Biotech plc, Guangzhou Wondfo Biotech Co. Ltd., Nova Biomedical Corp., Ortho Clinical Diagnostics Inc., Sekisui Diagnostics Inc., Abcam plc, Bio-Techne Corporation

What Are The Key Trends Of The Global Cardiac Biomarkers Testing Market? Strategic Partnerships Enhance Early Detection And Management Of Heart Conditions

Major companies operating in the cardiac biomarker testing market are adopting strategic partnerships to provide technology for detecting early warning signs of heart conditions and improving patient outcomes. Strategic partnerships in cardiac biomarker testing foster collaboration between companies, enabling the development of innovative diagnostics, expanding market reach, and accelerating the availability of advanced testing solutions for improved cardiovascular care. For instance, in September 2024, MediBuddy, an Indian-based healthcare technology company providing a comprehensive platform for telehealth services, health management, and insurance assistance, partnered with Philips, a Netherlands-based conglomerate corporation. With this partnership, they aim to enhance cardiac care in India by incorporating Philips' HeartPrint technology, enabling regular monitoring and risk assessment of heart health. This forward-thinking approach empowers users with advanced tools on the MediBuddy platform, fostering proactive management of heart health and better outcomes.

What Are The Key Trends Of The Global Cardiac Biomarkers Testing Market? Elevating Cardiovascular Care With Innovative Troponin I And Nt-Probnp Cardiac Biomarkers

Major companies operating in the cardiac biomarker testing market are focusing on innovative products such as cardiac biomarkers to drive revenues in their market. Cardiac biomarkers, also known as cardiac enzymes, are substances that are released into the bloodstream when the heart muscle is damaged. For instance, in October 2023, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., a China-based company developing medical equipment and solutions launched troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The hs-cTn assay has surpassed the minimal requirements for hs-cTn in terms of sensitivity, accuracy, and reliability in identifying myocardial damage. These new products are intended to support improved treatment for cardiovascular illnesses by giving dependable solutions that improve patient outcomes both within and beyond the context of cardiovascular illnesses.

Need data on a specific region in this market?
Request Customisation

Cardiac Biomarkers Testing Market Merger And Acquisition: Roche Acquires LumiraDx’s Point-of-Care Technology To Expand Decentralized Diagnostics Portfolio

In July 2024, Roche Holding AG, a Switzerland-based pharmaceutical company, acquired LumiraDx’s Point of Care technology for an undisclosed amount. This acquisition aims to enhance Roche's diagnostic portfolio, particularly in the area of decentralized diagnostics. By integrating LumiraDx’s innovative point-of-care platform, Roche seeks to strengthen its ability to provide rapid, accurate testing at or near patient locations. LumiraDx Ltd. is a UK-based hospital and healthcare company, specializes in offering cardiac biomarker testing, including the NT-proBNP test.

Regional Analysis For The Global Cardiac Biomarkers Testing Market

North America was the largest region in the cardiac biomarkers testing market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cardiac Biomarkers Testing Market?

The cardiac biomarkers testing market includes revenues earned by entities by providing ischemia-modified albumin (IMA), peptides, and C-reactive protein (CRP) biomarkers testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Cardiac Biomarkers Testing Industry?

The cardiac biomarkers testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac biomarkers testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Cardiac Biomarkers Testing Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $14.95 billion
Revenue Forecast In 2034 $23.24 billion
Growth Rate CAGR of 11.7% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Biomarkers Type: Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA), Other Biomarkers Types
2) By Application: Congestive Heart Failure, Acute Coronary Syndrome, Myocardial Infarction, Atherosclerosis, Other Applications
3) By End-User: Hospitals, Specialty Clinics Subsegments: 1) By Creatine Kinase (CK-MB): Total CK-MB, CK-MB Mass
2) By Troponins: Cardiac Troponin I (cTnI), Cardiac Troponin T (cTnT)
3) By Myoglobin: Total Myoglobin
4) By Natriuretic Peptides: B-Type Natriuretic Peptide (BNP), N-Terminal Pro B-Type Natriuretic Peptide (NT-ProBNP)
5) By Ischemia Modified Albumin (IMA): IMA Levels 6) By Other Biomarkers Types: C-Reactive Protein (CRP), Heart-Type Fatty Acid-Binding Protein (H-FABP), Soluble ST2
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Biomérieux SA, Becton Dickinson and Company, Randox Laboratories Ltd., Enzo Biochem Inc., Creative Diagnostics Inc., Merck Co. & KGaA, Beckman Coulter Inc., QIAGEN N.V., PerkinElmer Inc., Tosoh Corporation, Eurolyser Diagnostica GmbH, Cortez Diagnostics Inc., DIALAB GmbH, CardioGenics Holdings Inc., Lepu Medical Technology (Beijing) Co. Ltd., Biosynex SA, Charles River Laboratories, Quidel Corporation, Life Diagnostics, Trinity Biotech plc, Guangzhou Wondfo Biotech Co. Ltd., Nova Biomedical Corp., Ortho Clinical Diagnostics Inc., Sekisui Diagnostics Inc., Abcam plc, Bio-Techne Corporation
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Cardiac Biomarkers Testing Market Characteristics

3. Cardiac Biomarkers Testing Market Trends And Strategies

4. Cardiac Biomarkers Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cardiac Biomarkers Testing Growth Analysis And Strategic Analysis Framework

5.1. Global Cardiac Biomarkers Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Cardiac Biomarkers Testing Market Growth Rate Analysis

5.4. Global Cardiac Biomarkers Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Cardiac Biomarkers Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Cardiac Biomarkers Testing Total Addressable Market (TAM)

6. Cardiac Biomarkers Testing Market Segmentation

6.1. Global Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Creatine Kinase (CK-MB)

Troponins

Myoglobin

Natriuretic Peptides (BNP and NT-proBNP)

Ischemia Modified albumin (IMA)

Other Biomarkers Types

6.2. Global Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Congestive Heart Failure

Acute Coronary Syndrome

Myocardial Infarction

Atherosclerosis

Other Applications

6.3. Global Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Specialty Clinics

6.4. Global Cardiac Biomarkers Testing Market, Sub-Segmentation Of Creatine Kinase (CK-MB), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Total CK-MB

CK-MB Mass

6.5. Global Cardiac Biomarkers Testing Market, Sub-Segmentation Of Troponins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cardiac Troponin I (cTnI)

Cardiac Troponin T (cTnT)

6.6. Global Cardiac Biomarkers Testing Market, Sub-Segmentation Of Myoglobin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Total Myoglobin

6.7. Global Cardiac Biomarkers Testing Market, Sub-Segmentation Of Natriuretic Peptides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

B-Type Natriuretic Peptide (BNP)

N-Terminal Pro B-Type Natriuretic Peptide (NT-ProBNP)

6.8. Global Cardiac Biomarkers Testing Market, Sub-Segmentation Of Ischemia Modified Albumin (IMA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

IMA Levels

6.9. Global Cardiac Biomarkers Testing Market, Sub-Segmentation Of Other Biomarkers Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

C-Reactive Protein (CRP)

Heart-Type Fatty Acid-Binding Protein (H-FABP)

Soluble ST2

7. Cardiac Biomarkers Testing Market Regional And Country Analysis

7.1. Global Cardiac Biomarkers Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Cardiac Biomarkers Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cardiac Biomarkers Testing Market

8.1. Asia-Pacific Cardiac Biomarkers Testing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cardiac Biomarkers Testing Market

9.1. China Cardiac Biomarkers Testing Market Overview

9.2. China Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cardiac Biomarkers Testing Market

10.1. India Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cardiac Biomarkers Testing Market

11.1. Japan Cardiac Biomarkers Testing Market Overview

11.2. Japan Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cardiac Biomarkers Testing Market

12.1. Australia Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cardiac Biomarkers Testing Market

13.1. Indonesia Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cardiac Biomarkers Testing Market

14.1. South Korea Cardiac Biomarkers Testing Market Overview

14.2. South Korea Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cardiac Biomarkers Testing Market

15.1. Western Europe Cardiac Biomarkers Testing Market Overview

15.2. Western Europe Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cardiac Biomarkers Testing Market

16.1. UK Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cardiac Biomarkers Testing Market

17.1. Germany Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cardiac Biomarkers Testing Market

18.1. France Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cardiac Biomarkers Testing Market

19.1. Italy Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cardiac Biomarkers Testing Market

20.1. Spain Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cardiac Biomarkers Testing Market

21.1. Eastern Europe Cardiac Biomarkers Testing Market Overview

21.2. Eastern Europe Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cardiac Biomarkers Testing Market

22.1. Russia Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cardiac Biomarkers Testing Market

23.1. North America Cardiac Biomarkers Testing Market Overview

23.2. North America Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cardiac Biomarkers Testing Market

24.1. USA Cardiac Biomarkers Testing Market Overview

24.2. USA Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cardiac Biomarkers Testing Market

25.1. Canada Cardiac Biomarkers Testing Market Overview

25.2. Canada Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cardiac Biomarkers Testing Market

26.1. South America Cardiac Biomarkers Testing Market Overview

26.2. South America Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cardiac Biomarkers Testing Market

27.1. Brazil Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cardiac Biomarkers Testing Market

28.1. Middle East Cardiac Biomarkers Testing Market Overview

28.2. Middle East Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cardiac Biomarkers Testing Market

29.1. Africa Cardiac Biomarkers Testing Market Overview

29.2. Africa Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cardiac Biomarkers Testing Market Competitive Landscape And Company Profiles

30.1. Cardiac Biomarkers Testing Market Competitive Landscape

30.2. Cardiac Biomarkers Testing Market Company Profiles

30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.4. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Cardiac Biomarkers Testing Market Other Major And Innovative Companies

31.1. Thermo Fisher Scientific Inc.

31.2. Biomérieux SA

31.3. Becton Dickinson and Company

31.4. Randox Laboratories Ltd.

31.5. Enzo Biochem Inc.

31.6. Creative Diagnostics Inc.

31.7. Merck Co. & KGaA

31.8. Beckman Coulter Inc.

31.9. QIAGEN N.V.

31.10. PerkinElmer Inc.

31.11. Tosoh Corporation

31.12. Eurolyser Diagnostica GmbH

31.13. Cortez Diagnostics Inc.

31.14. DIALAB GmbH

31.15. CardioGenics Holdings Inc.

32. Global Cardiac Biomarkers Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiac Biomarkers Testing Market

34. Recent Developments In The Cardiac Biomarkers Testing Market

35. Cardiac Biomarkers Testing Market High Potential Countries, Segments and Strategies

35.1 Cardiac Biomarkers Testing Market In 2029 - Countries Offering Most New Opportunities

35.2 Cardiac Biomarkers Testing Market In 2029 - Segments Offering Most New Opportunities

35.3 Cardiac Biomarkers Testing Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Cardiac Biomarkers Testing Market, Sub-Segmentation Of Creatine Kinase (CK-MB), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Cardiac Biomarkers Testing Market, Sub-Segmentation Of Troponins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Cardiac Biomarkers Testing Market, Sub-Segmentation Of Myoglobin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Cardiac Biomarkers Testing Market, Sub-Segmentation Of Natriuretic Peptides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Cardiac Biomarkers Testing Market, Sub-Segmentation Of Ischemia Modified Albumin (IMA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Cardiac Biomarkers Testing Market, Sub-Segmentation Of Other Biomarkers Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Cardiac Biomarkers Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Cardiac Biomarkers Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Abbott Laboratories Financial Performance
  • Table 81: Bio-Rad Laboratories Inc. Financial Performance
  • Table 82: Danaher Corporation Financial Performance
  • Table 83: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 84: Siemens Healthineers AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Cardiac Biomarkers Testing Market, Sub-Segmentation Of Creatine Kinase (CK-MB), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Cardiac Biomarkers Testing Market, Sub-Segmentation Of Troponins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Cardiac Biomarkers Testing Market, Sub-Segmentation Of Myoglobin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Cardiac Biomarkers Testing Market, Sub-Segmentation Of Natriuretic Peptides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Cardiac Biomarkers Testing Market, Sub-Segmentation Of Ischemia Modified Albumin (IMA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Cardiac Biomarkers Testing Market, Sub-Segmentation Of Other Biomarkers Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Cardiac Biomarkers Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Cardiac Biomarkers Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Abbott Laboratories Financial Performance
  • Figure 81: Bio-Rad Laboratories Inc. Financial Performance
  • Figure 82: Danaher Corporation Financial Performance
  • Figure 83: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 84: Siemens Healthineers AG Financial Performance

Key Market Drivers, Trends, and Forecast for the Global Non-Steroidal Anti-inflammatory Drugs Industry

Read More About Key Market Drivers, Trends, and Forecast for the Global Non-Steroidal Anti-inflammatory Drugs Industry

Outlook for Non-Therapeutic Biomolecules Market: Key Developments and Future Strategies to 2029

Read More About Outlook for Non-Therapeutic Biomolecules Market: Key Developments and Future Strategies to 2029

Global Pain Management Drugs Market Forecast to Reach $104.19 Billion by 2029, Driven by 5.6% CAGR

Read More About Global Pain Management Drugs Market Forecast to Reach $104.19 Billion by 2029, Driven by 5.6% CAGR

Pericarditis Industry Poised for Rapid Expansion, Projected to Hit $3.37 Billion by 2029

Read More About Pericarditis Industry Poised for Rapid Expansion, Projected to Hit $3.37 Billion by 2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Read More About A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Read More About Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Robotic Process Automation Global Market Report 2024 – By Component (Software, Service), By Process (Automated Solution, Decision Support and Management Solutions, Interaction Solutions), By Operation (Rule Based, Knowle...

View Report

Private Banking Global Market Report 2025 – By Type (Asset Management Service, Insurance Service, Trust Service, Tax Consulting, Real Estate Consulting, Private Banking), By Bank Type (Full-Servics Banks, Tax Planning, B...

View Report

Silicon On Insulator (SOI) Global Market Report 2025 – By Type (Fully Depleted Silicon On Insulator (Fd-SoI), Partially Depleted Silicon On Insulator (Pd- SoI), Power- SoI, Other Types ), By Wafer Size (Less Than Or Equa...

View Report

Epoxy Composite Global Market Report 2025 – By Fiber Type (Glass Fiber, Carbon Fiber, Other Fiber Types), By Manufacturing Process (Lay-up, Compression Molding, Resin Injection, Resin Transfer Molding, Filament Winding, ...

View Report

Sustainability and Energy Management Software Global Market Report 2025 – By Software( Cloud based, On-Premise), By Module( Utility data management, Carbon reporting & management, Sustainability reporting & management, E...

View Report

Frequently Asked Questions

Cardiac biomarkers testing refers to the tests to evaluate the quantities of cardiac biomarkers in blood. It is used to diagnose, assess, and keep track of people who may have acute coronary syndrome (ACS). For further insights on this market, request a sample here

The market major growth driver - Rising Prevalence Of Cardiovascular Diseases Fuels Growth In The Cardiac Biomarkers Testing Market. For further insights on this market, request a sample here

The cardiac biomarkers testing market size has grown rapidly in recent years. It will grow from $13.48 billion in 2024 to $14.95 billion in 2025 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to increasing incidence of cardiovascular diseases, aging population, awareness and education initiatives, government initiatives and healthcare policies, increasing healthcare expenditure. The cardiac biomarkers testing market size is expected to see rapid growth in the next few years. It will grow to " $23.24 billion in 2029 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to personalized medicine, rising global burden of cardiovascular diseases, integration of artificial intelligence (ai) in diagnostics, expansion of point-of-care testing, increasing emphasis on early disease detection. Major trends in the forecast period include technological advancements, advancements in ai-assisted diagnostics, point-of-care testing (POCT) growth, multiplexing capabilities, biomarker discovery and validation. For further insights on this market, request a sample here

The cardiac biomarkers testing market covered in this report is segmented –
1) By Biomarkers Type: Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA), Other Biomarkers Types
2) By Application: Congestive Heart Failure, Acute Coronary Syndrome, Myocardial Infarction, Atherosclerosis, Other Applications
3) By End-User: Hospitals, Specialty Clinics Subsegments:
1) By Creatine Kinase (CK-MB): Total CK-MB, CK-MB Mass
2) By Troponins: Cardiac Troponin I (cTnI), Cardiac Troponin T (cTnT)
3) By Myoglobin: Total Myoglobin
4) By Natriuretic Peptides: B-Type Natriuretic Peptide (BNP), N-Terminal Pro B-Type Natriuretic Peptide (NT-ProBNP)
5) By Ischemia Modified Albumin (IMA): IMA Levels
6) By Other Biomarkers Types: C-Reactive Protein (CRP), Heart-Type Fatty Acid-Binding Protein (H-FABP), Soluble ST2 For further insights on this market, request a sample here

North America was the largest region in the cardiac biomarkers testing market in 2024. The regions covered in the cardiac biomarkers testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on this market, request a sample here.

Major companies operating in the cardiac biomarkers testing market include Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Biomérieux SA, Becton Dickinson and Company, Randox Laboratories Ltd., Enzo Biochem Inc., Creative Diagnostics Inc., Merck Co. & KGaA, Beckman Coulter Inc., QIAGEN N.V., PerkinElmer Inc., Tosoh Corporation, Eurolyser Diagnostica GmbH, Cortez Diagnostics Inc., DIALAB GmbH, CardioGenics Holdings Inc., Lepu Medical Technology (Beijing) Co. Ltd., Biosynex SA, Charles River Laboratories, Quidel Corporation, Life Diagnostics, Trinity Biotech plc, Guangzhou Wondfo Biotech Co. Ltd., Nova Biomedical Corp., Ortho Clinical Diagnostics Inc., Sekisui Diagnostics Inc., Abcam plc, Bio-Techne Corporation . For further insights on this market, request a sample here.

Major trends in this market include Strategic Partnerships Enhance Early Detection And Management Of Heart Conditions. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Cardiac Biomarkers Testing Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon